Fintel reports that on December 3, 2025, Roth Capital initiated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. As of November 17, 2025, the average one-year price target for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback